Laboratorios Farmaceuticos Rovi Aktie
| 61,00EUR | -0,50EUR | -0,81% |
WKN DE: A0M0GQ / ISIN: ES0157261019
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 1 419 | 1 751 | 1 993 | 2 111 | 2 197 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,30 | 0,37 | 0,41 | 0,39 | 0,35 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 372 | 510 | 625 | 511 | 492 |
| Summe Anlagevermögen | 202 | 223 | 254 | 289 | 340 |
| Summe Aktiva | 574 | 733 | 879 | 800 | 832 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 201 | 262 | 357 | 256 | 250 |
| Summe Eigenkapital | 374 | 471 | 521 | 543 | 582 |
| Summe Passiva | 574 | 733 | 879 | 800 | 832 |
Adresse
| Calle José Isbert, 2, 28223 Madrid | |
| Telefon | +34 (91) 021-30-00 |
| Fax | +34 (91) 304-78-81 |
| Internet | http://www.rovi.es |
Management
|
Aránzazu Lozano Pirrongelli
Head-Internal Auditor |
|
Beatriz Avila Alcalde
Sales Manager |
|
Enrique Castellón Leal
Independent Director |
|
Fernando Martínez Garijo
Manager-Sales Effectiveness |
|
Francisco Javier Ángulo García
Manager-Human Resources |
|
Gabriel Núñez Fernández
Secretary |
|
Ibón Gutierro Adúriz
Manager-Research & Development |
|
Iván López-Belmonte Encina
Second Vice Chairman, GM-Commercial & Development |
|
Javier López-Belmonte Encina
First Vice Chairman & Chief Financial Officer |
|
Juan López-Belmonte Encina
Executive Chairman & Chief Executive Officer |
|
M. Rosario Perucha Perez
Marketing Manager |
|
Marcos Peña Pinto
Lead Independent Director |
|
Marina del Corral Téllez
Director |
|
Marta Campos Martínez
Head-Investor Relations |
|
María Fátima Báñez García
Independent Director |
|
Mercedes Benitez del Castillo Sanchez
Manager-Legal Department |
|
Miguel Angel Castillo Román
Manager-International & Business Development |
|
Teresa Corzo Santamaría
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.